-
- News
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current Issue
Wire Harness Solutions
Explore what’s shaping wire harness manufacturing, and how new solutions are helping companies streamline operations and better support EMS providers. Take a closer look at what’s driving the shift.
Spotlight on Europe
As Europe’s defense priorities grow and supply chains are reassessed, industry and policymakers are pushing to rebuild regional capability. This issue explores how Europe is reshaping its electronics ecosystem for a more resilient future.
APEX EXPO 2026 Preshow
This month, we take you inside the annual trade show of the Global Electronics Association, to preview the conferences, standards, keynotes, and other special events new to the show this year.
- Articles
- Columns
- Links
- Media kit
||| MENU - smt007 Magazine
Benefited from Enhancing Bio-Sensing Technology, the Market in Wearable Device Applications to Reach $422 Million
January 22, 2024 | TrendForceEstimated reading time: 1 minute
In a pivotal ruling, the U.S. Court of Appeals for the Federal Circuit has decided against Apple in its patent dispute with Masimo, mandating a halt in sales of the Series 9 and Ultra 2 in the US due to their blood oxygen features. This decision pushes Apple to potentially remove these features via software updates temporarily. Despite this setback, TrendForce maintains a positive outlook on bio-sensing tech in the wearables market. Substantial growth is predicted, with the market value for bio-sensing in smartwatches and smart bands expected to reach US$422 million by 2028, growing a CAGR of 14.7% from 2023.
Market leaders in wearable devices, such as Apple, Samsung, and Google Fitbit, are actively advancing the bio-sensing sector. TrendForce’s 2024 forecast suggests a focus by Apple and Samsung on improving the precision of bio-sensing features in upcoming smartwatches. They plan to employ photoplethysmograph (PPG) technology for enhanced monitoring of heart rate and blood oxygen levels, furthering capabilities in personal health management.
TrendForce emphasizes two primary strategies among wearable device brands: Expanding bio-sensor features and enhancing their accuracy. This dual approach not only differentiates products but also boosts customer engagement and market growth. Bio-sensing, especially when merged with health management, shows promise for integration into medical, insurance, and automotive systems. As a result, securing comprehensive patents for both the software and hardware aspects of bio-sensing technology has become a critical focus for these companies.
Testimonial
"The I-Connect007 team is outstanding—kind, responsive, and a true marketing partner. Their design team created fresh, eye-catching ads, and their editorial support polished our content to let our brand shine. Thank you all! "
Sweeney Ng - CEE PCBSuggested Items
New Superconducting Chip Could Enable Breakthrough Nondestructive Terahertz Imaging
03/23/2026 | University of GlasgowA tiny crystal chip which uses terahertz radiation to see clearly through a wide range of materials could find applications in healthcare, biological research, and security screening.
Saab Receives Order for Trackfire Remote Weapon Station
01/09/2026 | SaabSaab has received an order from the Swedish Defence Materiel Administration, FMV, for the Trackfire Remote Weapon Station (RWS).
NEC, emaratech Collaborate on Biometric Smart Gates Supporting UAE Airport Operations
12/23/2025 | JCN NewswireNEC, a global leader in biometric and identity solutions, has teamed up with new windowemaratech, the UAE’s leading digital identity and border control provider, to deploy six advanced biometric smart gates at the crew immigration area within flydubai’s Airport Operations Centre in Dubai.
Smartkem Unlocks New Generation of Flexible Biometrics with World-First All-Organic Sensor
12/10/2025 | PRNewswireSmartkem, Inc., a company developing a new class of organic semiconductor technology, announced that it has created the world's first all-organic-transistor (AOT) biometric sensor, in collaboration with the SJTU.
Cadence Unveils AI-Driven ROCS X AI-Enabled Molecular Search, Unlocking Multi-trillion Molecule Virtual Screening
09/29/2025 | Cadence Design SystemsCadence Molecular Sciences (OpenEye), a business unit of Cadence, announced at miniCUP Boston, the launch of ROCS X, an AI-enabled virtual-- screening solution that allows scientists to conduct 3D searches of trillions of drug-like molecules.